Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2007, Vol. 5 ›› Issue (5): 521-525.doi: 10.3736/jcim20070509

• Original Clinical Research • Previous Articles     Next Articles

Mechanism of salvianolate in preventing postoperative intestinal adhesion in rats

Xin-bin Sui1, Qing Zhang2, Hua-sen Qiu2,Ji-chun Zhou2,Xi-dong Gu1, Zhou-xiang Lu1, Chao Li1, Gang Wang1   

  1. 1. First Clinical Medical College,Zhejiang University of Traditional Chinese Medicine,Hangzhou,Zhejiang Province 310053,China
    2. Department of Gastrointestinal Surgery,Zhejiang Hospital of Traditional Chinese Medicine,Hangzhou,Zhejiang Province 310053,China
  • Online:2007-09-20 Published:2007-09-15

Objective: To observe the effects of salvianolate on rats with postoperative intestinal adhesion and to explore the prevention mechanism.Methods: Forty SD male rats with intestinal adhesion were randomly divided into four groups: untreated group, low-dose salvianolate-treated group (12 mg/kg), medium-dose salvianolate-treated group (24 mg/kg) and high-dose salvianolate-treated group (48 mg/kg), with another ten SD male rats as normal control. Intraperitoneal injection of glucose was administered to the rats in the normal control group and the untreated group, and intraperitoneal injection of salvianolate was administered to the rats in the low-, medium- and high-dose salvianolate-treated groups. They were all treated for 8 days and once a day. On the eighth day after surgery the blood samples of each group were collected. Grades of intestinal adhesion were ranked by macroscopic observation. The adhesive tissues between viscera and belly wall were taken for pathological observation. The levels of interleukin-1β (IL-1β), interleukin-4 (IL-4) and tumor necrosis factor-α (TNF-α) were determined by enzyme linked immunosorbent assay.Results: Salvianolate can significantly reduce the extent of postoperative intestinal adhesion, obviously decrease the levels of IL-1β, TNF-α and inhibit the hyperplasy of fibrous connective tissue. However, there was no significant impact on the level of IL-4.Conclusion: Salvianolate can reduce the extent of postoperative intestinal adhesion, decrease the expression of IL-1β and TNF-α and inhibit the hyperplasy of fibrous connective tissue. This may be the mechanism of salvianolate in preventing intestinal adhesion.

CLC Number: 

  • R574

Table 1

Grades of intestinal adhesion in different groups"

Group n Grade of intestinal adhesion
0
Normal control 10 8 2 0 0 0
Untreated* 10 0 1 0 7 2
Low-dose salvianolate-treated 10 3 2 1 2 2
Medium-dose salvianolate-treated 10 6 2 2 0 0
High-dose salvianolate-treated 10 7 3 0 0 0

Figure 1

Grades of intestinal adhesion in different groupsA: Normal control group (grade 0); B: Untreated group (grade Ⅲ); C: Untreated group (grade Ⅳ); D: Low-dose salvianolate-treated group (grade Ⅱ); E: Medium-dose salvianolate-treated group (grade Ⅰ); F: High-dose salvianolate-treated group (grade Ⅰ)."

Table 2

Levels of cytokines expressions in blood serum in different groups (ヌ±S, ng/L)"

Group n IL-1β IL-4 TNF-α
Normal control group 10 166.59±37.29 335.07±64.13 60.45±21.95
Untreated group 10 216.66±28.46* 315.00±40.77 119.69±50.37*
Low-dose salvianolate-treated 10 212.68±25.14 331.57±65.12 75.91±47.27
Medium-dose salvianolate-treated 10 168.40±26.14 348.15±51.70 74.56±23.83
High-dose salvianolate-treated 10 166.73±37.94 355.36±47.16 69.51±39.00

Figure 2

Grades of tissue adhesion in different groups (HE staining, ×20) A: Normal control group (grade Ⅰ); B: Untreated group (grade Ⅲ); C: Low-dose salvianolate-treated group (grade Ⅱ); D: Medium-dose salvianolate-treated group (grade Ⅰ); E: High-dose salvianolate-treated group (grade Ⅰ)."

Table 3

Observation results of intestinal adhesion by HE staining in different groups"

Group n
Normal control group 10 9 1 0
Untreated group* 10 1 2 7
Low-dose salvianolate-treated 10 3 3 4
Medium-dose salvianolate-treated 10 6 3 1
High-dose salvianolate-treated 10 7 2 1
[1] 曾健, 李晓辉 . 腹膜粘连的分子机制及药物防治[J]. 世界华人消化杂志, 2003,11(9):1429-1432
Zeng J, Li XH . Molecular mechanisms of peritoneal adhesions and drug prevention[J]. Shi Jie Hua Ren Xiao Hua Za Zhi, 2003,11(9):1429-1432
[2] Hugh TB, Ellis H . Postoperative abdominal adhesions.An experimental study of the value of polyvinylpyrrolidone in prophylaxis[J]. Br J Surg, 1964,51(5):381-382
[3] Nair SK, Bhat IK, Aurora AL . Role of proteolytic enzymes in the prevention of post-operative intra-peritoneal adhesions[J]. Arch Surg, 1974,108(6):846-853
doi: 10.1001/archsurg.1974.01350300081019 pmid: 4829809
[4] 刘洪斌, 李东华, 郭世铎 . 腹腔粘连形成机制及治疗研究进展[J]. 中国中西医结合外科杂志, 2005,11(1):84-86
Liu HB, Li DH, Guo SD . Abdominal adhesion formation mechanism and treatment progress[J]. Zhongguo Zhong Xi Yi Jie He Wai Ke Za Zhi, 2005,11(1):84-86
[5] Yang XX, Shi HP, Ho B . Chinese medicine compound Changtong oral liquid on postoperative intestinal adhesions[J]. World J Gastroenterol, 2005,11(19):2967-2970
doi: 10.1186/1471-230x-5-16 pmid: 15902738
[6] 杨小进, 毛勤生, 周新泽 . 大鼠腹膜粘连的病理学特征及血清中IL-6、TNF-α的变化[J]. 中国交通医学杂志, 2005,19(2):104-106
Yang XJ, Mao QS, Zhou XZ . Pathological characteristics of peritoneal adhesion in rats and changes of interleukin-6 and tumor necrosis factor-alpha in blood[J]. Zhongguo Jiao Tong Yi Xue Za Zhi, 2005,19(2):104-106
[7] 陈弹, 程绪杰, 李红霞 , 等. 卡维地洛及TNF-α对内皮细胞释放t-PA和PAI-1的影响[J]. 实用临床医药杂志, 2003,7(5):448-449,452
Chen T, Cheng XJ, Li HX , et al. The effects of carvedilol and TNF-α on endothelial cell secreting t-PA and PAI-1[J]. Shi Yong Lin Chuang Yi Yao Za Zhi, 2003,7(5):448-449,452
[8] Nakamura K, Honda K, Mizutani T , et al. Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules[J]. World J Gastroenterol, 2006,12(29):4628-4635
[9] 杨雁灵, 窦科峰, 李开宗 . 应用IL-1β抗体预防术后腹腔粘连实验研究[J]. 西北国防医学杂志, 2002,23(6):429-430
Yang YL, Dou KF, Li KZ . Prevention of postoperative abdominal adhesions by IL-1 beta antibody[J]. Xi Bei Guo Fang Yi Xue Za Zhi, 2002,23(6):429-430
[10] Sung MJ, Kim W, Ahn SY , et al. Protective effect of alpha-lipoic acid in lipopolysaccharide-induced endothelial fractalkine expression[J]. Circ Res, 2005,97(9):880-890
[11] 尚晓滨, 吴咸中, 邱奇 , 等. 活血化瘀中药对清解通下中药增效作用的实验研究Ⅲ——对粘连相关细胞因子影响的实验研究[J]. 中国中西医结合外科杂志, 2006,12(3):250-253
Shang XB, Wu XZ, Qiu Q , et al. Experimental study on synergistic actions of herbs of Huoxue Huayu on Qingjie Tongxia herbs Ⅲ--Influence on adhesion relative cytokines of peritoneal adhesions in rats[J]. Zhongguo Zhong Xi Yi Jie He Wai Ke Za Zhi, 2006,12(3):250-253
[1] Xin-zu Chen, Tao Wei, Kun Jiang, Kun Yang, Bo Zhang, Zhi-xin Chen, Jia-ping Chen, Jian-kun Hu. Etiological factors and mortality of acute intestinal obstruction:a review of 705 cases. Journal of Chinese Integrative Medicine, 2008, 6(10): 1010-1016.
[2] Hong-qiang Wei, Zong-wen Huang, Hui Li. Early treatment with integrated traditional Chinese and Western medicine in adhesive intestinal obstruction. Journal of Chinese Integrative Medicine, 2008, 6(10): 1062-1064.
[3] Chun-mei He, Jin-gen Lu, Yong-qing Cao. Effects of Yiqi Kaimi Recipe on gastrointestinal motility and neuropeptides in rats with colonic slow transit constipation. Journal of Chinese Integrative Medicine, 2007, 5(2): 160-164.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[3] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[4] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[5] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[6] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[7] Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92
[8] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[9] Xin-jun Wang, Ling-ling Wang . A mechanism of endogenous opioid peptides for rapid onset of acupuncture effect in treatment of depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1014-1017
[10] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022